Is Johnson & Johnson a Buy?
The pros and the cons for this giant healthcare stock.
Editors' Picks
Does Anheuser-Busch InBev Have Any Growth on Tap in Q2?
The brewer surprised the market last quarter, but it has a heavy debt load to carry, which weighs it down.
3 Reasons for Netflix Investors to Worry After the Latest Report
Shares of the streaming-TV giant dove after its latest report, and for good reason.
3 Stocks to Buy and Hold for Decades
It takes a few decades for compounding to work its wealth-building magic.
Recent articles
Who Is Peloton For?
Early adopters may not be who the company needs to attract.
Sunrun Has Found a Way to Crack Energy Storage Markets
A new business model may be emerging in solar energy.
Is Microsoft's Hottest Growth Engine Losing Its Spark?
Cloud infrastructure platform Azure’s revenue growth decelerates again in its latest quarterly earnings, but its margins are improving.
Is CSX a Buy?
It was a disappointing set of earnings, but is the stock worth buying now, or should investors dump it?
Where Will Sirius-XM Holdings Be in 5 Years?
A lot of things can go right -- and wrong -- for the satellite radio giant between now and 2024.
3 Ways United Airlines Is Taking a Different Path
The world's third-largest airline has made an impressive comeback with some unconventional strategic choices over the past couple of years.
Can Boston Beer Keep the Momentum Going in Q2?
The craft brewer has turned its business around by developing non-beer alcoholic beverages.
Hasbro Could Romp in Its Q2 Showing
A lineup of blockbuster movies and a better financial outlook hint at what's in store for the toy maker.
Skechers Stock Gets Back on the Right Path
The leading walking-footwear specialist bounces back from a rough first quarter with a blowout second-quarter performance.
Should Investors Worry About J.C. Penney's Debt?
The retailer challenges a recent report that it’s trying to restructure its debt.
Colgate Makes Its Largest Acquisition in Over 20 Years
Colgate is acquiring Laboratoires Filorga for $1.7 billion. Does this deal fit within the company's growth strategy?
3 Health Savings Account Mistakes to Avoid
Have an HSA? Don't make these costly blunders.
Only 9% of Workers Can Answer This Social Security Question
Not being able to answer this question can impact your benefits for the rest of your life.
Everything You Need to Know About Marijuana Legalization 2.0
Derivative cannabis products will soon hit licensed Canadian dispensaries.
Google Parent Alphabet's Earnings: What to Watch on Thursday
Will the tech giant's advertising sales growth continue to decelerate when it reports Q2 results?
Does Anheuser-Busch InBev Have Any Growth on Tap in Q2?
The brewer surprised the market last quarter, but it has a heavy debt load to carry, which weighs it down.
Could Bad Credit Prevent You From Getting a Job?
Yes, mismanaging your finances has an even bigger impact than you think.
Will Aurora, Canopy, Cronos, and Tilray Be Profitable by 2021?
Rapid sales growth yields no guarantee of profitability in the cannabis space.
3 Good Reasons to File for Social Security After Full Retirement Age
Here's why it pays to wait.
Is Johnson & Johnson a Buy?
The pros and the cons for this giant healthcare stock.